Christian Koch, MD
Endocrinology, Diabetes & Metabolism · Jacksonville, FLNPI 1033156187
Payments from drug & device makers
Across 21 payments — averaging $569.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ascendis Pharma Endocrinology Inc$9K
- IBSA Pharma Inc.$1K
- Bayer$972
- AstraZeneca$304
- Dexcom, Inc.$245
- Medtronic$142
- plus $42 from 1 others
What the payments were for
- Consulting fees$1,97216%
- Speaking & faculty fees$8,49071%
- Travel & lodging$2732%
- Food & beverage$1,22910%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ascendis Pharma Endocrinology Inc | 7 | $9,133 |
| IBSA Pharma Inc. | 2 | $1,125 |
| Bayer | 1 | $972 |
| AstraZeneca | 3 | $304 |
| Dexcom, Inc. | 4 | $245 |
| Medtronic | 2 | $142 |
| Kyowa Kirin, Inc. | 2 | $42 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tirosint$1,125
- Tirosint-SOL$1,125
- Vitrakvi$972
- Strensiq$126
How this compares
$11,964 in reported general payments places this provider in the 65th percentile of 586 endocrinology, diabetes & metabolism providers in Florida.
See all endocrinology, diabetes & metabolism providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 13 | $11,628 |
| SynthroidLevothyroxine Sodium | 17 | $1,859 |
| Ultra-Fine Mini Pen NeedlePen Needle, Diabetic | 13 | $915 |
| Levothyroxine Sodium | 53 | $537 |
| Humulin RInsulin Regular, Human | 11 | $427 |
| Alendronate Sodium | 28 | $271 |
| Gabapentin | 15 | $193 |
| Metformin Hcl | 22 | $148 |
Paid to pharmacies, not to this prescriber.
Other endocrinology, diabetes & metabolism in Jacksonville
- David SuttonJacksonville$3.1M
- Mae Sheikh AliJacksonville$2.9M
- James MageeJacksonville$2.7M
- Senan SultanJacksonville$2.5M
- J EvansJacksonville$1.7M
- Wasim DeebJacksonville$1.5M
- Ricardo SilvaJacksonville$867K
- Anil ShresthaJacksonville$602K
- Joe ChehadeJacksonville$542K
- Firas WardaJacksonville$440K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.